CIRM hosted its 2011 Grantee Meeting in San Francisco, bringing together the stem cell scientists and trainees that the institute is funding. This leading edge event helps these researchers exchange…
J. Craig Venter gave the keynote address at the 2011 California Institute for Regenerative Medicine (CIRM) Grantee Meeting. Venter's cutting-edge topics included creation of the first synthetic life and exploration…
*Please note: this video contains graphic images of a disfiguring disease John Wagner presented the closing scientific talk at the 2011 CIRM Grantee Meeting. Weaving together stories of medical history,…
Ellen Feigal, MD, led a workshop at the 2011 CIRM Grantee Meeting on the Target Product Profile (TPP). The TPP is a methodology for summarizing a drug development program which…
Karen Aboody speaks at the 2011 CIRM Grantee Meeting about the developing a stem cell-based clinical trial for malignant brain tumors. Dr. Aboody and her team at the City of…
Mathew Blurton-Jones speaks at the 2011 CIRM Grantee Meeting about promising research which uses neural stem cells to improve learning and memory in mice with alzheimer's like symptoms.
Dennis Clegg speaks at the 2011 CIRM Grantee Meeting about the development of a stem-cell based therapy for macular degeneration, the leading cause of blindness in the elderly. Clegg is…
Eugene Brandon speaks at the 2011 CIRM Grantee Meeting about Viacyte's efforts to develop a stem cell based treatment for diabetes. CIRM has awarded Viacyte $26 million to support their…
Paula Cannon speaks at the 2011 CIRM Grantee Meeting about a stem cell-based therapy for HIV/AIDS. Cannon is a co-principle investigator on a disease team that has the goal of…
Daniel Goff speaks at the 2011 CIRM Grantee Meeting about identifying potential leukemia drugs that could zero-in on and kill the cancer stems cells that are thought to be responsible…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
